ES2012556A6 - Metodo de produccion del factor de creacimiento transformante beta 2. - Google Patents

Metodo de produccion del factor de creacimiento transformante beta 2.

Info

Publication number
ES2012556A6
ES2012556A6 ES8803023A ES8803023A ES2012556A6 ES 2012556 A6 ES2012556 A6 ES 2012556A6 ES 8803023 A ES8803023 A ES 8803023A ES 8803023 A ES8803023 A ES 8803023A ES 2012556 A6 ES2012556 A6 ES 2012556A6
Authority
ES
Spain
Prior art keywords
beta
tgf
mature
cells
tamoxifen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8803023A
Other languages
English (en)
Spanish (es)
Inventor
Anthony F Purchio
Linda Madisen
Nancy Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of ES2012556A6 publication Critical patent/ES2012556A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES8803023A 1987-10-06 1988-10-05 Metodo de produccion del factor de creacimiento transformante beta 2. Expired - Lifetime ES2012556A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10675287A 1987-10-06 1987-10-06
US14826788A 1988-01-25 1988-01-25
US23406588A 1988-08-18 1988-08-18

Publications (1)

Publication Number Publication Date
ES2012556A6 true ES2012556A6 (es) 1990-04-01

Family

ID=27380183

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8803023A Expired - Lifetime ES2012556A6 (es) 1987-10-06 1988-10-05 Metodo de produccion del factor de creacimiento transformante beta 2.

Country Status (22)

Country Link
JP (1) JPH02444A (de)
KR (1) KR970001236B1 (de)
CN (1) CN1035845A (de)
AT (1) AT398433B (de)
BE (1) BE1002693A5 (de)
CH (1) CH680002A5 (de)
DE (1) DE3833897C2 (de)
DK (1) DK556388A (de)
ES (1) ES2012556A6 (de)
FI (1) FI884546A (de)
FR (1) FR2621324B1 (de)
GB (1) GB2210620B8 (de)
GR (1) GR1000492B (de)
IE (1) IE60918B1 (de)
IL (1) IL87877A0 (de)
IT (1) IT1227957B (de)
MY (1) MY103779A (de)
NL (1) NL8802442A (de)
NO (1) NO884429L (de)
NZ (1) NZ226486A (de)
PT (1) PT88670B (de)
SE (1) SE8803528L (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
CN100389120C (zh) * 2005-04-12 2008-05-21 中国人民解放军第三军医大学野战外科研究所 封闭TGF-β1的反义寡核苷酸及其在制备治疗纤维化相关疾病药物中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169016B2 (de) * 1984-07-16 2004-04-28 Celtrix Pharmaceuticals, Inc. Knorpel-induzierende Polypeptid-Faktoren aus Knochen
IL78197A (en) * 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
NZ222569A (en) * 1986-11-17 1990-08-28 Sandoz Ltd Production of glioblastoma-derived t cell suppressor factor (g-tsf) using recombinant techniques
AU1340688A (en) * 1987-01-30 1988-08-24 Techne Corporation Transforming growth factor-beta
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity

Also Published As

Publication number Publication date
GB2210620A (en) 1989-06-14
ATA245488A (de) 1994-04-15
IE60918B1 (en) 1994-08-24
SE8803528D0 (sv) 1988-10-05
IT8822213A0 (it) 1988-10-06
FI884546A0 (fi) 1988-10-03
BE1002693A5 (fr) 1991-05-07
DK556388D0 (da) 1988-10-05
CH680002A5 (de) 1992-05-29
NO884429L (no) 1989-04-07
DE3833897C2 (de) 1997-03-20
DE3833897A1 (de) 1989-05-03
NO884429D0 (no) 1988-10-05
IL87877A0 (en) 1989-03-31
AT398433B (de) 1994-12-27
NZ226486A (en) 1991-08-27
IE883018L (en) 1989-04-06
GB2210620B (en) 1992-07-08
CN1035845A (zh) 1989-09-27
JPH02444A (ja) 1990-01-05
DK556388A (da) 1989-04-07
FR2621324B1 (fr) 1994-02-18
MY103779A (en) 1993-09-30
KR890006814A (ko) 1989-06-16
FI884546A (fi) 1989-04-07
SE8803528L (sv) 1989-04-07
PT88670B (pt) 1992-12-31
GR1000492B (el) 1992-07-30
GB2210620B8 (en) 1995-07-17
IT1227957B (it) 1991-05-20
KR970001236B1 (ko) 1997-02-04
NL8802442A (nl) 1989-05-01
GB8823448D0 (en) 1988-11-16
FR2621324A1 (fr) 1989-04-07

Similar Documents

Publication Publication Date Title
EP0429586B1 (de) Wachstumshormonfusionsproteine
HUT63438A (en) Process for producing epitelines, new proteins controlling cysteine-rich growth
BG38166A3 (en) Method for preparing polypeptide including expression of its heterologic from recombinant microbial cloning vector
EP0376785A3 (de) Klonierung und Expression des transformierenden Wachstumsfaktors beta 2
IE822281L (en) Microbial expression of dna sequences
Nicoll et al. The primary structure of coho salmon growth hormone and its cDNA
DE506574T1 (de) Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
ES8504255A1 (es) Procedimiento para la produccion de una hormona de crecimiento de porcino.
ES2012556A6 (es) Metodo de produccion del factor de creacimiento transformante beta 2.
Negro et al. Synthesis, purification, and characterization of human ciliary neuronotrophic factor from E. coli
EP0587571A4 (de) Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen.
FI81378C (fi) Dna som kodar foer en prekursor till hpgrf, expressionsvektor och foerfarande foer expression av en prekursor till hpgrf.
Ullrich et al. Sequence homology of human and mouse β-NGF subunit genes
RU2004133974A (ru) Полипептид, обладающий расщепляющей активностью по отношению к полисахариду, содержащему сульфатированную фукозу, способ его получения, кодирующие его последовательность днк и экспрессирующий вектор, способ получения трансформированной клетки e. coli
MY108190A (en) Curculin b and dna encoding same,and process for production thereof.
EP0261625A3 (en) Human b-cell differentiation factor and process of producing said factor
Troxell et al. Sequence and genomic organization of the Drosophila proteasome PROS-Dm25 gene
Hatsuzawa et al. Purification of mouse Ren 2 prorenin produced in Chinese hamster ovary cells
HUP9903959A2 (hu) Csonkított vérlemezke-aktiváló faktor acetilhidroláz
EP0192743A4 (de) Modifizierte insulinvorläufererzeugnisse und verfahren.
CA2253233A1 (en) Process for producing maturation bone morphogenetic protein
Agostino et al. Cloning and nucleotide sequence analysis of complementary deoxyribonucleic acid for bovine preproinsulin
Tsuji et al. Structural and biological identity of recombinant EDF (erythroid differentiation factor) with natural EDF
JPS6474989A (en) Dna to code human lysozyme
HK1017817A1 (en) Novel cytokine

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-10-05